Cramer's 'Mad Money' Follow-Up: Jan. 25 - TheStreet

NEW YORK (TheStreet) -- Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.


I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them

," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to

do his or her own homework


That said, here's how some of the stocks that Cramer talked about on

Friday's "Mad Money" show

fared today.


(AAPL) - Get Report

: Cramer said not to buy Apple, which

reported earnings today

, until after its new-product introduction on Wednesday. The stock, which he owns for his

Action Alerts PLUS

charitable trust, tends to sell off ahead of product launches, Cramer said.

On Monday, Apple gained $5.32, or 2.7%, to close at $203.07.

Cogent Communications

(CCOI) - Get Report

: For Speculative Friday, Cramer suggested as a speculative play Internet provider Cogent, which he said has grown quickly into an alternative to the bundled voice/data/television service packages often offered by major telcos.

On Monday, Cogent closed up a penny at $11.50.


(UNH) - Get Report

: Cramer told viewers it was time to sell lesser-performing health care stocks such as UnitedHealth,


(HUM) - Get Report



( RHB). He said President Obama's health care reform plans are done supporting these stocks, and the easy money was already made.

On Monday, UnitedHealth lost 16 cents, or 0.5%, to close at $33; Humana slid $1.44, or 2.8%, to $49.56; and Rehabcare added $1.07, or 3.6%, to $31.07.

Bristol-Myers Squibb

(BMY) - Get Report

: Bristol-Myers, which Cramer owns for

Action Alerts PLUS

, was once health care stock Cramer still liked, along with



, which he said could go to $90 a share, and




On Monday, Bristol-Myers gave up 27 cents, or 1.1%, to $24.33; WellPoint closed up 45 cents or 0.7%, at $65.55; and Covidien added 3 cents to $50.78.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC


At the time of publication, Cramer was long Apple.

Jim Cramer is a director and co-founder of He contributes daily market commentary for's sites and serves as an adviser to the company's CEO. Outside contributing columnists for and, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click

here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click

here to order his book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from